F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
Source:
nytimes
August 26, 2026 · 08:23
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
The original article opens on the publisher's website.
More from General
View topic →Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate
nprNews
Sep 1, 2026 · 17:38
Apple Maps changes Lake Ontario to Lake America after Trump order
bbcTechnology
Sep 1, 2026 · 17:36
Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics
nytimes
Sep 1, 2026 · 16:57
Tim Cook to be paid $47mn as Apple’s executive chair
financialTimes
Sep 1, 2026 · 16:38
Are all TVs at risk from burn-in? Here's how to avoid the problem altogether
engadget
Sep 1, 2026 · 16:30